With the gift, the center hopes to develop early "proof-of-concept" findings, enabling ADRC researchers to apply for funding from the National Institutes of Health and other sources to more rapidly move innovation out of the laboratory and into the community. In recent years, cutbacks in research funding from the federal government and other sources has put increased pressure on researchers to find funding for new, early-stage projects. The center is one of just thirteen NIH-supported comprehensive research centers and the only such entity in the Southeast.
The Alzheimer's Association estimates that in 2014 the cost of providing care for Alzheimer's patients in the United States was $214 billion, including $150 billion in Medicare and Medicaid costs. If present trends continue, the total cost of caring for Alzheimer's patients is projected to grow to $1.2 trillion annually by 2050.
"Our father believed in making smart investments where the outcomes may be uncertain but the rewards could be great," said Goizueta Foundation chair and CEO Olga Goizueta Rawls. "It's likely that everyone in the Atlanta community and beyond knows someone who has been affected by some form of dementia, such as Alzheimer's. We believe that strengthening Emory's ADRC will help generate the much-needed support for innovative research for all neuro-related diseases."